Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ)

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Oncogene

• Publication date

  2019-08-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41388-019-0957-5PMID 31420607PMCID PMC6895402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenvironmental factors

  2018cited by this paper
• TSC2 regulates microRNA biogenesis via mTORC1 and GSK3&bgr;

  2018cited by this paper
• TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review

  2017cited by this paper
• Rapamycin-induced miR-21 promotes mitochondrial homeostasis and adaptation in mTORC1 activated cells

  2017cited by this paper
• MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

  2017cited by this paper
• mTORC1 signaling and the metabolic control of cell growth.

  2017cited by this paper
• Tuberous sclerosis complex

  2016cited by this paper
• The Emerging Role of Inhibitor of Growth 4 as a Tumor Suppressor in Multiple Human Cancers

  2015cited by this paper
• An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation.

  2015cited by this paper
• The role of miR-29b in cancer: regulation, function, and signaling

  2015cited by this paper
• Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation

  2014cited by this paper
• Comprehensive molecular characterization of urothelial bladder carcinoma

  2014cited by this paper
• Diverse roles of miR-29 in cancer (review).

  2014cited by this paper
• Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4.

  2014cited by this paper
• Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

  2013cited by this paper
• miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease

  2013cited by this paper
• MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM)

  2013cited by this paper
• An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis.

  2013cited by this paper
• The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia

  2013cited by this paper
• Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin–integrin signalling in head and neck squamous cell carcinoma

  2013cited by this paper
• Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial.

  2013cited by this paper
• COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA

  2013cited by this paper
• A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng

  2013cited by this paper
• Effect of miR-29b-1* and miR-29c knockdown on cell growth of the bladder cancer cell line T24

  2013cited by this paper
• Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.

  2013cited by this paper
• A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7

  2012cited by this paper
• miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial–Mesenchymal Transition Signaling

  2012cited by this paper
• Negative Regulation of NF-κB by the ING4 Tumor Suppressor in Breast Cancer

  2012cited by this paper
• Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm.

  2012cited by this paper
• miR-29b regulates migration of human breast cancer cells

  2011cited by this paper
• An atlas of combinatorial transcriptional regulation in mouse and man.

  2010cited by this paper
• An Atlas of Combinatorial Transcriptional Regulation in Mouse and Man (vol 140, pg 744, 2010)

  2010cited by this paper
• Transcriptional suppression of mir‐29b‐1/mir‐29a promoter by c‐Myc, hedgehog, and NF‐kappaB

  2010cited by this paper
• Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.

  2010cited by this paper
• MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

  2009cited by this paper
• miR-29 miRNAs activate p53 by targeting p85α and CDC42

  2009cited by this paper
• Molecular Basis of Histone H3K4me3 Recognition by ING4*

  2008cited by this paper
• Role of ING4 in human melanoma cell migration, invasion and patient survival.

  2008cited by this paper
• Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.

  2008cited by this paper
• mir-29 regulates Mcl-1 protein expression and apoptosis

  2007cited by this paper
• Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1.

  2007cited by this paper
• MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

  2007cited by this paper
• ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.

  2006cited by this paper
• MicroRNAs as oncogenes and tumor suppressors.

  2005cited by this paper
• Impaired Retinoic Acid (RA) Signal Leads to RARβ2 Epigenetic Silencing and RA Resistance

  2005cited by this paper
• Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-β2 expression

  2005cited by this paper
• Metastasis of benign tumor cells in tuberous sclerosis complex

  2003cited by this paper
• Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

  2000cited by this paper
• Evidence That Retinoic Acid Receptor β Induction by Retinoids Is Important for Tumor Cell Growth Inhibition*

  2000cited by this paper
• Molecular genetic advances in tuberous sclerosis

  2000cited by this paper
• Induction of a RAR beta 2-lacZ transgene by retinoic acid reflects the neuromeric organization of the central nervous system.

  1992cited by this paper
• Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes.

  1989cited by this paper

• The development for emerging biomarkers of lymphangioleiomyomatosis

  2024cites this paper
• Inhibition of CK2/ING4 Pathway Facilitates Non‐Small Cell Lung Cancer Immunotherapy

  2023cites this paper
• Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy

  2022cites this paper
• Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects

  2021cites this paper
• Roles of the tumor suppressor inhibitor of growth family member 4 (ING4) in cancer.

  2021cites this paper
• Noncoding RNAs and RNA-binding proteins in diabetic wound healing.

  2021cites this paper
• Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells

  2021cites this paper
• CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis

  2021cites this paper
• Sequential Release of Small Extracellular Vesicles from Bilayered Thiolated Alginate/Polyethylene Glycol Diacrylate Hydrogels for Scarless Wound Healing.

  2021cites this paper
• Normalization of enzyme expression and activity regulating vitamin A metabolism increases RAR-beta expression and reduces cellular migration in diseases caused by tuberous sclerosis gene mutations

  2020cites this paper
• Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations

  2020cites this paper
• Retinoic acid and microRNA.

  2020cites this paper
• Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenvironmental factors

  2018cites this paper